Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T J Simon

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Neuroimage. Clinical|November 13, 2021
Atypical attentional filtering of visual information in youth with chromosome 22q11.2 deletion syndrome as indexed by event-related potentialsS R Linton, A M Popa, S J Luck, et al.
The American Journal of Gastroenterology|December 1, 1996
Comparison of once-daily doses of omeprazole (40 and 20 mg) and placebo in the treatment of benign gastric ulcer: a multicenter, randomized, double-blind studyJ E Valenzuela, D G Kogut, A J McCullough, et al.
Alimentary Pharmacology & Therapeutics|June 26, 1999
Specific inhibition of cyclooxygenase-2 with MK-0966 is associated with less gastroduodenal damage than either aspirin or ibuprofenF L Lanza, M F Rack, T J Simon, et al.
JAMA|December 2, 1999
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDsM J Langman, D M Jensen, D J Watson, et al.
Alimentary Pharmacology & Therapeutics|May 20, 2003
Famotidine for infant gastro-oesophageal reflux: a multi-centre, randomized, placebo-controlled, withdrawal trialS R Orenstein, T M Shalaby, S N Devandry, et al.
The New England Journal of Medicine|May 30, 1996
Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugsA S Taha, N Hudson, C J Hawkey, et al.
Alimentary Pharmacology & Therapeutics|April 1, 1997
Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind studyS J Sontag, M Robinson, W Roufail, et al.
Gastroenterology|March 1, 1997
Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591W G Roberts, T J Simon, R G Berlin, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Neuroimage. Clinical|November 13, 2021
Atypical attentional filtering of visual information in youth with chromosome 22q11.2 deletion syndrome as indexed by event-related potentialsS R Linton, A M Popa, S J Luck, et al.
The American Journal of Gastroenterology|December 1, 1996
Comparison of once-daily doses of omeprazole (40 and 20 mg) and placebo in the treatment of benign gastric ulcer: a multicenter, randomized, double-blind studyJ E Valenzuela, D G Kogut, A J McCullough, et al.
Alimentary Pharmacology & Therapeutics|June 26, 1999
Specific inhibition of cyclooxygenase-2 with MK-0966 is associated with less gastroduodenal damage than either aspirin or ibuprofenF L Lanza, M F Rack, T J Simon, et al.
JAMA|December 2, 1999
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDsM J Langman, D M Jensen, D J Watson, et al.
Alimentary Pharmacology & Therapeutics|May 20, 2003
Famotidine for infant gastro-oesophageal reflux: a multi-centre, randomized, placebo-controlled, withdrawal trialS R Orenstein, T M Shalaby, S N Devandry, et al.
The New England Journal of Medicine|May 30, 1996
Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugsA S Taha, N Hudson, C J Hawkey, et al.
Alimentary Pharmacology & Therapeutics|April 1, 1997
Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind studyS J Sontag, M Robinson, W Roufail, et al.
Gastroenterology|March 1, 1997
Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591W G Roberts, T J Simon, R G Berlin, et al.
Pageof 3